Management consultancy in FR. Official registry identity, filed financial evidence and a public indicative value curve on one indexed company profile.
Historical rounded range based on the latest available public filing for fiscal year 2018. This is not a current market value or asking price.
Based on filed company accountsThe historical curve shows where this company stood. Unlock what holds back value today, what it could be in five years and which actions matter now.
Free account · private workspace
Public filings are a starting point. Accounts, owner context and method review narrow the range and make it useful for a sale, financing or transfer.
Own this company? Claim and manage the profileYou have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The historical indicative range for NGUYEN LINH EMMA PHARMA CONSULTANCY uses the latest available public filing and sector calibration. It is not a current market value or asking price; current owner or advisor data is needed for a full valuation.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
NGUYEN LINH EMMA PHARMA CONSULTANCY, a management consultancy, is registered at an address in France. The company was founded in 2013, incorporated as a 5710.
NGUYEN LINH EMMA PHARMA CONSULTANCY is listed in French National Business Register (RNE/INPI) under registry number 793908120. This profile consolidates official annual accounts into one indexable company dossier.
Companies in this NACE 70.22 band file annual accounts with INPI.
The most recently filed revenue (2018) stands at €49,300.
The most recent annual filing covers 2018 (period end 2018-12-31).
The historical indicative range for NGUYEN LINH EMMA PHARMA CONSULTANCY is a point-in-time research aid, not a current market value or asking price; current owner or advisor data is required for a full valuation.
Public regulator-filed figures across 3 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 201831 Dec 2018 | €49,300 | - | €28,146 | €20,285 | - |
| 201731 Dec 2017 | €30,500 | - | €20,299 | €14,675 | - |
| 201631 Dec 2016 | - | - | €6,752 | €6,752 | - |
NGUYEN LINH EMMA PHARMA CONSULTANCY was founded in 2013 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
NGUYEN LINH EMMA PHARMA CONSULTANCY is registered under NACE 70.22: NACE 70.22. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2018 (period end 2018-12-31), publicly available via French National Business Register (RNE/INPI).
This page shows a rounded historical indicative range for NGUYEN LINH EMMA PHARMA CONSULTANCY, based on the latest available public filing for fiscal year 2018. It is not a current market value, asking price, certified or statutory valuation, or financial, investment, tax or legal advice. Verify current figures before relying on it for any decision or transaction.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
